Persistent Remodeling of Resistance Arteries in Type 2 Diabetic Patients on Antihypertensive Treatment

Hypertension

Volumn 43, Issue 2, 2004, Pages 399-404

  Endemann, Dierk H ^a   Pu, Qian ^a   De Ciuceis, Carolina ^a   Savoia, Carmine ^a   Virdis, Agostino ^a   Neves, Mario F ^a   Touyz, Rhian M ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Angiotensin converting enzyme inhibitors; Diabetes mellitus; Endothelium; Hypertension, detection and control; Remodeling

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERY ENDOTHELIUM; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; FEMALE; GLUTEUS MAXIMUS MUSCLE; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; MYOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESSURE; PRIORITY JOURNAL; PULSE PRESSURE; RESISTANCE BLOOD VESSEL; SUBCUTANEOUS TISSUE; SYSTOLIC BLOOD PRESSURE; TISSUE REGENERATION; VASCULAR TISSUE; VASODILATATION;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ARTERIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VASCULAR RESISTANCE; VASODILATION;

EID: 0842289889     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.0000112029.03691.e7     Document Type: Article

References (31)

1. Adler AI, Stratton IM, Neil HAW, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000; 321: 412-419.
2. UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ. 1998; 317: 703-713.
3. Henry RM, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Kamp O, Westerhof N, Bouter LM, Stehouwer CD. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation. 2003; 107: 2089-2095.
4. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 1995; 91: 1432-1443.
5. Emoto M, Nishizawa Y, Kawagishi T, Maekawa K, Hiura Y, Kanda H, Izumotani K, Shoji T, Ishimura E, Inaba M, Okuno Y, Morii H. Stiffness indexes β of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care. 1998; 21: 1178-1182.
6. Park JB, Charbonneau F, Schiffrin EL. Correlation of endothelial function in large and small arteries in human essential hypertension. J Hypertens. 2001; 19: 415-420.
7. Park JB, Schiffrin EL. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens. 2001; 19: 921-930.
8. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Piccoli A, Valentini U, Cimino A, Girelli A, Salvetti M, De Ciuceis C, Tiberio GA, Giulini SM, Sleiman I, Monteduro C, Rosei EA. Endothelial dysfunction in small resistance arteries of patients with non-insulin-dependent diabetes mellitus. J Hypertens. 2001; 19: 913-919.
9. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Rosei EA. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation. 2001; 103: 1238-1244.
10. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation. 2002; 106: 3037-3043.
11. Schiffrin EL, Deng LY, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994; 23: 83-91.
12. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor: comparison with effects of a β-blocker. Am J Hypertens. 1995; 8: 229-236.
13. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 2000; 101: 1653-1659.
14. Schiffrin EL, Park JB, Pu Q. Effect of crossing over hypertensive patients from a β-blocker to an angiotensin receptor antagonist on resistance artery structure and endothelial function. J Hypertens. 2002; 20: 71-78.
15. 1-receptor antagonist losartan in essential hypertension. J Renin Angiotens Aldost Syst. 2000; 1: 40-45.
16. Schiffrin EL, Pu Q, Park JB. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Am J Hypertens. 2002; 15: 105-110.
17. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B. Losartan Intervention for Endpoint reduction in hypertension Study Investigations: regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study. Circulation. 2003; 108: 684-690.
18. Schiffrin EL, Deng LY. Comparison of effects of angiotensin I-converting enzyme inhibition and β-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension. 1995; 25: 699-703.
19. Schiffrin EL. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension. 1995; 26: 716-717.
20. Schiffrin EL, Deng LY. Relationship between small-artery structure and systolic, diastolic, and pulse pressure in essential hypertension. J Hypertens. 1999; 17: 381-387.
21. James MA, Watt PAC, Potter JF, Thurston H, Swales JD. Pulse pressure and resistance artery structure in the elderly. Hypertension. 1995; 26: 301-306.
22. Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jerums G, Gilbert RE. Vascular hypertrophy in experimental diabetes: role of advanced glycation end products. J Clin Invest. 1997; 99: 1016-1027.
23. Kamide K, Hori MT, Zhu JH, Takagawa Y, Barrett JD, Eggena P, Tuck ML. Insulin and insulin-like growth factor-I promotes angiotensinogen production and growth in vascular smooth muscle cells. J Hypertens. 2000; 18: 1051-1056.
24. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992; 263: H321-H326.
25. Rizzoni D, Porteri E, Boari G, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small artery structure in hypertension. Circulation. 2003; 108: 2230-2235.
26. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension. 1995; 25 (pt 1): 474-481.
27. Schiffrin EL, Schiffrin A. Hypertension and diabetes, a dangerous liaison. Can J Diabetes Care. 2002; 26: 206-214.
28. Diep QN, El Mabrouk M, Cohn JS, Endemann D, Amiri F, Virdis A, Fritsch Neves M, Schiffrin EL. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-γ. Circulation. 2002; 105: 2296-2302.
29. Diep QN, Amiri F, Touyz RM, Cohn JS. Endemann D, Schiffrin EL. PPARα activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension. 2002; 40: 866-871.
30. Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, Freed MI. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation. 2002; 106: 679-684.
31. Longhini CS, Scorzoni D, Bazzanini F, Manservigi D, Fratti D, Gilli G, Musacci GF. The structural arteriolar changes in diabetes mellitus and essential hypertension: the relative contribution of ageing and high blood pressure. Eur Heart J. 1997; 18: 1135-1140.